Cardiology in Review最新文献_第2页

Review and Key Takeaways of the 2021 Percutaneous Coronary Intervention Guidelines. 2021年经皮冠状动脉介入治疗指南的回顾和关键要点。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-09-20 DOI: 10.1097/CRD.0000000000000608

Haris Patail, Atul Bali, Tanya Sharma, William H Frishman, Wilbert S Aronow

引用次数: 0

A Concise Review of Marfan Syndrome with a Congenital Cardiac Surgery Focus. 以先天性心脏外科为重点的马凡氏综合症简明综述。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2024-10-24 DOI: 10.1097/CRD.0000000000000619

Andrew D Vogel, Gabriela M Galan, T Konrad Rajab

{"title":"A Concise Review of Marfan Syndrome with a Congenital Cardiac Surgery Focus.","authors":"Andrew D Vogel, Gabriela M Galan, T Konrad Rajab","doi":"10.1097/CRD.0000000000000619","DOIUrl":"10.1097/CRD.0000000000000619","url":null,"abstract":"Marfan syndrome is named after Antoine Marfan, who described a 5-year-old child with congenital elongation of the digits and other skeletal abnormalities in 1896. While Marfan syndrome is a systemic connective tissue disorder predominantly involving the skeletal, cardiovascular, and ocular systems, the cardiovascular system presents the most life-threatening complications. Most cardiovascular pathologies surround the left ventricular outflow tract and aorta, with aortic dissection requiring emergent surgical management to the progression of mitral regurgitation requiring elective surgery. Intensive care management, along with a tailored approach to the surgical management of a patient with Marfan syndrome, is critical to their survival. Current surgical operations for patients include aortic root surgery, valve-sparing root replacements, aortic root replacements with conduits, and mitral valve repairs. Further research is necessary to determine the molecular, endovascular, pharmaceutical, and surgical management of Marfan syndrome. This review attempts to concisely discuss the diagnosis, complications, and medical and intensive care management of Marfan syndrome while further divulging on the surgical management of those with this disease process.","PeriodicalId":9549,"journal":{"name":"Cardiology in Review","volume":" ","pages":"166-170"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142495706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Left Atrial Appendage Closure: What Do We Know? 左心耳闭合:我们知道些什么?

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-08-29 DOI: 10.1097/CRD.0000000000000601

Savalan Babapoor-Farrokhran, Jafar Alzubi, Zachary Port, Risheek Kaul, Roozbeh Tarighati Rasekhi, Ali Babapour Farrokhran, Naveen Sooknanan, Philip C Wiener, Ola Khraisha, William H Frishman, Sumeet K Mainigi, Wilbert S Aronow

{"title":"Left Atrial Appendage Closure: What Do We Know?","authors":"Savalan Babapoor-Farrokhran, Jafar Alzubi, Zachary Port, Risheek Kaul, Roozbeh Tarighati Rasekhi, Ali Babapour Farrokhran, Naveen Sooknanan, Philip C Wiener, Ola Khraisha, William H Frishman, Sumeet K Mainigi, Wilbert S Aronow","doi":"10.1097/CRD.0000000000000601","DOIUrl":"10.1097/CRD.0000000000000601","url":null,"abstract":"Atrial fibrillation (AF) is the most common arrhythmia in the United States and the most common cause of embolic cerebrovascular events, with the majority of these thrombi originating in the left atrial appendage. The left atrial appendage (LAA) has separate developmental, ultrastructural, and physiological characteristics from the left atrium. Although LAA anatomy is highly variable, it can be categorized into 4 types: cactus, cauliflower, chicken wing, and windsock. The cauliflower type is associated with higher stroke risk in patients with nonvalvular AF. Although the cornerstone of therapy to prevent embolic strokes from AF has been anticoagulation with thrombin inhibitors, a large group of patients are unable to tolerate anticoagulation due to bleeding. This has led to the development and advancement of multiple surgical and percutaneous LAA closure devices to prevent embolic cerebrovascular accidents without the need for anticoagulation. In this article, we discuss the outcomes of major studies that utilized surgical LAA occlusion and its effectiveness. Furthermore, we summarize nonsurgical methods of LAA closure and future directions regarding LAA closure.","PeriodicalId":9549,"journal":{"name":"Cardiology in Review","volume":" ","pages":"153-159"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10103705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

PCSK9 Inhibitors - A New Hope for Dyslipidemia in HIV. PCSK9抑制剂——治疗HIV血脂异常的新希望

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-11-29 DOI: 10.1097/CRD.0000000000000587

Sanjana Datla, Sundeep Kumar

引用次数: 0

Prognostic Implication of Preprocedural Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis. 接受经导管主动脉瓣植入术的重度主动脉瓣狭窄患者术前肺动脉高压的预后影响：系统综述与 Meta 分析》。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2024-01-29 DOI: 10.1097/CRD.0000000000000583

Mahmood Emami Meybodi, Atefe Bamarinejad, Fateme Bamarinejad, Amir Parsa Abhari, Mohammad Fakhrolmobasheri, Fareheh Khosravi Larijani, Shidrokh Nasiri, Davood Shafie

{"title":"Prognostic Implication of Preprocedural Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis.","authors":"Mahmood Emami Meybodi, Atefe Bamarinejad, Fateme Bamarinejad, Amir Parsa Abhari, Mohammad Fakhrolmobasheri, Fareheh Khosravi Larijani, Shidrokh Nasiri, Davood Shafie","doi":"10.1097/CRD.0000000000000583","DOIUrl":"10.1097/CRD.0000000000000583","url":null,"abstract":"Pulmonary hypertension (PH) is a common comorbidity in patients with aortic stenosis (AS) who are candidates for transcatheter aortic valve implantation (TAVI). Herein, we sought to elucidate the prognostic value of preprocedural PH on the early and late mortality after TAVI. The Cochrane Library, Scopus, PubMed, Web of Science, Embase, and ProQuest were screened using a predefined search query. We considered odds ratios (ORs) as the measure of effect. Meta-regression analysis was applied to investigate the potential impact of baseline characteristics on the outcomes. Egger's and Begg's tests were used to assess the publication bias. Thirty-three studies comprising 34 datasets representing 68,435 patients were included in the analysis. Regardless of the definition and severity of PH, pooled data analysis indicated that preprocedural PH was associated with higher cardiac and overall 30-day [OR, 1.45 (1.15-1.82) and OR, 1.75 (1.42-2.17), respectively], and 1-year mortality [OR, 1.63 (1.35-1.96) and OR, 1.59 (1.38-1.82), respectively]. Meta-regression analysis demonstrated that older age, higher New York Heart Association function class, history of hypertension, diabetes, and lower left ventricular ejection fraction were predictors of higher mortality rate following TAVI. Moreover, we found that preprocedural PH is significantly associated with higher in-hospital mortality and 30-day acute kidney injury. Our results demonstrated that preprocedural PH is associated with higher early and late cardiac and overall mortality following TAVI; however, this finding is limited regarding the considerable inconsistency in the definition of PH and PH severity among studies.","PeriodicalId":9549,"journal":{"name":"Cardiology in Review","volume":" ","pages":"120-128"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139575223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Understanding the Interplay between Iron Deficiency and Congestive Heart Failure: A comprehensive review. 了解缺铁和充血性心力衰竭之间的相互作用:一个全面的回顾。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-08-29 DOI: 10.1097/CRD.0000000000000603

Kopal Kotak, Kanishk Aggarwal, Shreya Garg, Vasu Gupta, Fnu Anamika, Rohit Jain

引用次数: 0

Cardiotoxicity of Breast Cancer Chemotherapy. 乳腺癌化疗的心脏毒性。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2025-02-03 DOI: 10.1097/CRD.0000000000000589

Sacha A Roberts, William H Frishman

引用次数: 0

Istaroxime: A Novel Therapeutic Agent for Acute Heart Failure. 依他肟：一种治疗急性心力衰竭的新型药物。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-10-09 DOI: 10.1097/CRD.0000000000000598

Danielle Newbury, William Frishman

{"title":"Istaroxime: A Novel Therapeutic Agent for Acute Heart Failure.","authors":"Danielle Newbury, William Frishman","doi":"10.1097/CRD.0000000000000598","DOIUrl":"10.1097/CRD.0000000000000598","url":null,"abstract":"Acute decompensated heart failure (ADHF) is a multifactorial process that is associated with high morbidity and mortality. Treatment with inotropes can rapidly improve hemodynamic status; however, their use has been associated with increased mortality and incidence of arrhythmias. Istaroxime is a first-in-class intravenous agent currently undergoing clinical trials for acute heart failure. It has the unique mechanism of action of both Na + /K + ATPase inhibition and sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2a stimulation. Notably, its action on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2a improves calcium handling, which is known to be abnormal in heart failure. Clinical trials have shown that istaroxime has beneficial hemodynamic effects; in particular, its ability to increase systolic blood pressure without causing significant increases in heart rate or clinically significant arrhythmias differentiates it from inotropes currently utilized for ADHF treatment, such as milrinone. While initial studies are encouraging, additional trials are needed to assess outcomes and to compare their performance to standard inotropes in patients hospitalized with ADHF. This article will review the relevant preclinical and clinical trials for istaroxime, as well as the relevant pharmacology.","PeriodicalId":9549,"journal":{"name":"Cardiology in Review","volume":" ","pages":"187-190"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41105469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

New Therapy Update Aprocitentan: An Endothelin Receptor Antagonist for the Treatment of Drug-Resistant Systemic Hypertension. 阿普昔坦:一种内皮素受体拮抗剂治疗耐药全身性高血压。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-08-02 DOI: 10.1097/CRD.0000000000000591

Michael Airo, WIlliam H Frishman, Wilbert S Aronow

引用次数: 0

Long Saphenous Vein Harvesting: Reviewing Various Techniques. 长隐静脉采收:各种技术综述。

IF 2 4区医学

Cardiology in Review Pub Date : 2025-03-01 Epub Date: 2023-07-03 DOI: 10.1097/CRD.0000000000000580

Momna Sajjad Raja, Bea Duric, Arwa Khashkhusha, Hannah Abbasi, Kartik Goyal, Amer Harky

引用次数: 0